Comparison of toxicity following different conditioning regimens (busulfan/melphalan and carboplatin/etoposide/melphalan) for advanced stage neuroblastoma: Experience of two transplant centers-Reference-Cited by-同舟云学术

Comparison of toxicity following different conditioning regimens (busulfan/melphalan and carboplatin/etoposide/melphalan) for advanced stage neuroblastoma: Experience of two transplant centers

Published:2015-11-28 Issue:2 Volume:20 Page:284-289
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplantation

Author:

Elborai Yasser¹²³⁴^ORCID,Hafez Hanafy¹⁴,Moussa Emad A.⁴,Hammad Mahmoud¹⁴,Hussein Hany¹⁴,Lehmann Leslie²,Elhaddad Alaa¹⁴

Affiliation:

1. Pediatric Oncology Department; National Cancer Institute (NCI); Cairo University; Cairo Egypt

2. Pediatric Stem Cell Transplantation Unit; Dana Farber/Children's Hospital Cancer Care Center; Boston MA USA

3. Pediatric Hematology/Oncology and Stem Cell Transplant Unit; Prince Sultan Military Medical City (PSMMC); Riyadh Saudi Arabia

4. Pediatric Oncology and Bone Marrow Transplant Department; Children's Cancer Hospital Egypt (CCHE-57357); Cairo Egypt

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/petr.12638/fullpdf

Reference16 articles.

1. Neuroblastoma;Maris;Lancet,2007

2. Molecular genetics of neuroblastoma and the implications for clinical management: A review of the MSKCC experience;Mora;Oncologist,2001

3. Advances in the diagnosis and treatment of neuroblastoma;Weinstein;Oncologist,2003

4. Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study;Schmidt;J Clin Oncol,2000

5. Stem cell transplantation for neuroblastoma;Fish;Bone Marrow Transplant,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION.;Mediterranean Journal of Hematology and Infectious Diseases;2023-08-29

2. High-dose thiotepa, in conjunction with melphalan, followed by autologous hematopoietic stem cell transplantation in patients with pediatric solid tumors, including brain tumors;Bone Marrow Transplantation;2022-11-03

3. Pediatric high risk neuroblastoma with autologous stem cell transplant – 20 years of experience;International Journal of Pediatrics and Adolescent Medicine;2021-12

4. Innovative therapies for neuroblastoma: The surprisingly potent role of iron chelation in up-regulating metastasis and tumor suppressors and down-regulating the key oncogene, N-myc;Pharmacological Research;2021-11

5. Transplantation for ultra high-risk neuroblastoma patients: effect of tandem autologous stem cell transplantation;Journal of Health Sciences and Medicine;2021-09-24